SNBL USA Announces Grand Opening of New Facility in Texas

With SNBL USA SRC, the commitment to test system quality & availability continues

Alice, TX – July 11, 2007 - SNBL USA, one of the nation’s leading preclinical testing companies, has announced the opening of its Texas facility, SNBL USA Scientific Resource Center (SNBL USA SRC), in Alice, TX today. This milestone is being acknowledged with an open house event on site of the facility with special guests including representatives from the pharmaceutical/ biotechnology industries and county and city officials who have been invited to personally tour SNBL USA SRC.

"SNBL USA purchased 500 acres in Jim Wells County, TX in February of 2006 with the vision of building a new facility (SNBL USA SRC) to provide: SPF Production Breeding; Maintenance of Client-Specific Colonies; Specialized Model Development; Extensive Laboratory Services; Test Systems Pre-trained for Study Activities; Genetic and Viral Screening; and Large Quarantine Capabilities. Today’s Grand Opening of SNBL USA SRC marks a significant first step in making these services available to our clients," said Steven Meyer, SNBL USA President.

"With the initial build out of our Texas facility, SNBL USA is essentially building for the future,” Meyer continues. “SNBL USA SRC represents SNBL USA’s commitment to our clients that includes the vision to supply consistent, readily available, quality NHP test systems. With our experienced staff on the ready to see this vision come to fruition, we are in a great position to provide what our clients are seeking - accessibility to quality test systems that will in turn, help facilitate innovative science into life-changing therapies."

About SNBL USA, Ltd.

Headquartered in Everett, WA, SNBL USA, Ltd. is a preclinical CRO that specializes in nonhuman primate (NHP) and small animal research. Study programs range from regulatory toxicology to customized study designs and disease models. Specialized programs include reproductive toxicology, safety pharmacology, immunotoxicology and carcinogenicity. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. If you are interested in SNBL USA, please contact us at (425) 407-0121 or info@snblusa.com.